Announcement AD/PD 2017
We invite you to join our poster presentation at the upcoming International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, held in Vienna, Austria from March 29th to April 2nd. The groundbreaking series of Alzheimer's and Parkinson's Diseases Conferences attract international medical and scientific professionals worldwide.
EVER will use this opportunity to present the latest findings in preclinical research:
- NEUROPROTECTIVE EFFECTS OF CEREBROLYSIN IN TRIPLE REPEAT (3R) TAU TRANSGENIC MODEL OF PICK'S DISEASE AND FRONTO-TEMPORAL TAUOPATHIES
Poster presentation on March 29th, 2017 by Hemma Brandstaetter, Austria
Free access to the publication on https://bmcneurosci.biomedcentral.com/articles/10.1186/s12868-015-0218-7
- INCREASED SERUM BDNF AND COGNITIVE IMPROVEMENT IN AD PATIENTS TREATED WITH CEREBROLYSIN ALONE OR PLUS DONEPEZIL
Poster presentation on March 30th, 2017 by Antòn Alvarez, Spain
Free access to the publication on https://academic.oup.com/ijnp/article/19/6/pyw024/2639564/Synergistic-Increase-of-Serum-BDNF-in-Alzheimer?searchresult=1
- META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS WITH CEREBROLYSIN IN MILD TO MODERATE ALZHEIMER’S DISEASE
Poster presentation on April 1st, 2017 by Lutz Frölich, Germany
Also please stop by at the EVER booth #08 in the exhibtion area. We are looking forward to meeting you there.